(Q39775909)

14 September 2017

title

CYT997 causes apoptosis in human multiple myeloma (English)

1 reference

14 September 2017

0 references

Katherine Monaghan

1

1 reference

14 September 2017

Tiffany Khong

series ordinal

2

1 reference

14 September 2017

Gregg Smith

series ordinal

3

1 reference

14 September 2017

Andrew Spencer

series ordinal

4

1 reference

14 September 2017

publication date

12 November 2009

1 reference

Investigational New Drugs

14 September 2017

published in

1 reference

14 September 2017

volume

29

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

232-238

1 reference

https://scigraph.springernature.com/pub.10.1007/s10637-009-9350-5

14 September 2017

exact match

0 references

cites work

A tale of two tumor targets: topoisomerase I and tubulin. The Wall and Wani contribution to cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10637-009-9350-5

Dynamic instability of microtubule growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-009-9350-5

The treatment of multiple myeloma with docetaxel (an ECOG study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-009-9350-5

Discovery of CYT997: a structurally novel orally active microtubule targeting agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-009-9350-5

Patupilone (epothilone B) inhibits growth and survival of multiple myeloma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-009-9350-5

Microtubule stabilizing agents: their molecular signaling consequences and the potential for enhancement by drug combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-009-9350-5

Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.

21 January 2018

1 reference

12 December 2020

Multiple myeloma therapies

1 reference

12 December 2020

P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy.

1 reference

12 December 2020

Interleukin 6 differentially potentiates the antitumor effects of taxol and vinblastine in U266 human myeloma cells

1 reference

12 December 2020

CYT997: a novel orally active tubulin polymerization inhibitor with potent cytotoxic and vascular disrupting activity in vitro and in vivo.

1 reference

12 December 2020

Body condition scoring: a rapid and accurate method for assessing health status in mice

1 reference

12 December 2020

New tubulin targeting agents currently in clinical development

1 reference

12 December 2020

Primary therapy of multiple myeloma with paclitaxel (taxol)

1 reference

12 December 2020

Paclitaxel as the initial treatment of multiple myeloma: an Eastern Cooperative Oncology Group Study (E1A93)

1 reference

12 December 2020

10.1007/S10637-009-9350-5

Identifiers

DOI

1 reference

14 September 2017

1 reference